Drug Type Antibody fusion proteins |
Synonyms + [1] |
Target |
Mechanism IL-2R agonists(Interleukin-2 receptor agonists), PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Solid Tumor | Phase 1 | NL | 04 May 2020 | |
Metastatic Solid Tumor | Phase 1 | DK | 04 May 2020 | |
Metastatic Solid Tumor | Phase 1 | CA | 04 May 2020 | |
Metastatic Solid Tumor | Phase 1 | ES | 04 May 2020 | |
Metastatic Solid Tumor | Phase 1 | PL | 04 May 2020 | |
Metastatic Solid Tumor | Phase 1 | BE | 04 May 2020 |